Search Results for "Drug Interactions"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug Interactions. Results 371 to 380 of 1090 total matches.
COVID-19 Update: Metformin to Prevent Long Covid?
The Medical Letter on Drugs and Therapeutics • May 29, 2023 (Issue 1677)
is not recommended.
DRUG INTERACTIONS – Metformin is a substrate of
organic cation transporter 1 (OCT1 ...
Results from a double-blind trial suggest that off-label
use of the oral antihyperglycemic drug metformin
in patients with COVID-19 may decrease the risk
of post-acute sequelae of SARS-CoV-2 infection
("long COVID").
Med Lett Drugs Ther. 2023 May 29;65(1677):87-8 doi:10.58347/tml.2023.1677e | Show Introduction Hide Introduction
Alprazolam (Xanax, and others) Revisited
The Medical Letter on Drugs and Therapeutics • Jan 17, 2005 (Issue 1200)
for product labeling. Clin Pharmacol Ther 2000; 67:335.
15. Drug interactions with grapefuit juice. Med Lett ...
Alprazolam, a short-acting benzodiazepine, is one of the most widely prescribed drugs in the US. It is approved by the FDA for treatment of anxiety and panic disorder. An extended-release formulation, Xanax XR, which can be taken once a day, recently became available for panic disorder.
Micafungin (Mycamine) for Fungal Infections
The Medical Letter on Drugs and Therapeutics • Jun 20, 2005 (Issue 1211)
. Isolated cases of anaphylaxis
and hemolysis have been reported.
DRUG INTERACTIONS — Micafungin ...
Micafungin sodium (Mycamine - Astellas), the second echinocandin antifungal to become available in the US, has been approved by the FDA for intravenous treatment of esophageal candidiasis and prophylaxis of invasive Candida infections in patients undergoing hematopoietic stem cell transplantation (HSCT).
Dextromethorphan/Bupropion (Auvelity) for Depression
The Medical Letter on Drugs and Therapeutics • Dec 26, 2022 (Issue 1666)
, benzodiazepines, barbituates, or
antiseizure drugs.
Drug Interactions: May interact with many other drugs ...
The FDA has approved an extended-release fixed-dose
combination of dextromethorphan and
bupropion (Auvelity – Axsome) for treatment of major
depressive disorder (MDD) in adults.
Clevidipine (Cleviprex) for IV Treatment of Severe Hypertension
The Medical Letter on Drugs and Therapeutics • Sep 22, 2008 (Issue 1295)
, M.D. Albert Einstein College of Medicine
CONTRIBUTING EDITOR, DRUG INTERACTIONS: Philip D. Hansten ...
Clevidipine (Cleviprex - The Medicines Company), a dihydropyridine calcium channel blocker (CCB), has been approved by the FDA for intravenous (IV) use in lowering high blood pressure. It is the second IV CCB to be marketed in the US; nicardipine has been available in an IV formulation (Cardene IV) for more than 10 years. Like IV nicardipine, clevidipine will probably be used mainly for urgent treatment of hypertension in intensive care units, operating rooms and emergency departments.
Edoxaban (Savaysa) - The Fourth New Oral Anticoagulant
The Medical Letter on Drugs and Therapeutics • Mar 30, 2015 (Issue 1465)
of the INR, dietary restrictions, and
concerns about its interactions with many other drugs.
The new oral ...
The FDA has approved edoxaban (Savaysa – Daiichi
Sankyo), a once-daily, oral, direct factor Xa inhibitor,
for treatment of venous thromoboembolism (VTE)
and for prevention of stroke and systemic embolism
in patients with nonvalvular atrial fibrillation. It is the
fourth new oral anticoagulant to be approved for VTE
and nonvalvular atrial fibrillation.
Dexlansoprazole (Kapidex) for GERD and Erosive Esophagitis
The Medical Letter on Drugs and Therapeutics • Mar 23, 2009 (Issue 1308)
. Treatment of peptic ulcers and GERD. Treat Guidel Med Lett
2008; 6:55.
6. M Vakily et al. Drug interaction ...
The FDA has approved the proton-pump inhibitor (PPI) dexlansoprazole (Kapidex - Takeda), a delayed release formulation of the R-enantiomer of lansoprazole (Prevacid - Takeda), for treating and maintaining healing of erosive esophagitis and for treatment of heartburn associated with non-erosive gastroesophageal reflux disease (GERD).
Quetiapine (Seroquel) and QT-Interval Prolongation
The Medical Letter on Drugs and Therapeutics • Oct 03, 2011 (Issue 1374)
or increased serum concentrations
due to drug interactions or renal and/or hepatic
insufficiency.
Women ...
The FDA has required the manufacturer of the secondgeneration
antipsychotic quetiapine (Seroquel) to add a
warning to the labeling saying that use of the drug should
be avoided in combination with other drugs that prolong
the electrocardiographic QTc interval (Table 1). The
warning is based only on postmarketing reports of QT-interval
prolongation in patients who overdosed on the
drug, had concomitant illness, or were taking other drugs
known to cause electrolyte imbalances or increase the
QT interval. QT prolongation can lead to torsades de
pointes, a potentially fatal cardiac...
Rifaximin (Xifaxan 550) for Hepatic Encephalopathy
The Medical Letter on Drugs and Therapeutics • Nov 01, 2010 (Issue 1350)
The Medical Letter®
On Drugs and Therapeutics
Volume 52 (Issue 1350)
November 1, 2010 ...
The FDA has approved a new 550-mg tablet of rifaximin (Xifaxan – Salix), a minimally absorbed oral
antibiotic, to reduce the risk of recurrent hepatic encephalopathy (HE). A 200-mg tablet has been available
for treatment of travelers’ diarrhea since 2004.
Treatment of Atrial Fibrillation
The Medical Letter on Drugs and Therapeutics • Jan 08, 2024 (Issue 1693)
are available at www.
warfarindosing.org.
Drug Interactions – Maintaining the INR within
the desired range ...
Atrial fibrillation (AF) is the most common arrhythmia
in the world. Risk factor modification, anticoagulation,
rhythm control, and rate control are the four pillars
of its management. American College of Cardiology/American Heart Association (ACC/AHA) guidelines
on management of AF were updated recently.
Med Lett Drugs Ther. 2024 Jan 8;66(1693):1-8 doi:10.58347/tml.2024.1693a | Show Introduction Hide Introduction